Publicacions en què col·labora amb JUAN PABLO RODRIGO TAPIA (19)

2022

  1. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Immune cell infiltrates and neutrophil-to-lymphocyte ratio in relation to response to chemotherapy and prognosis in laryngeal and hypopharyngeal squamous cell carcinomas

    Cancers, Vol. 13, Núm. 9

2020

  1. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

    Oral Oncology, Vol. 110

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  3. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813

2017

  1. A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

    Scientific Reports, Vol. 7, Núm. 1

  2. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation

    Oncotarget, Vol. 8, Núm. 8, pp. 13730-13746

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

  2. Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain

    European Archives of Oto-Rhino-Laryngology, Vol. 273, Núm. 12, pp. 4549-4559

2015

  1. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas

    Scientific Reports, Vol. 5

2014

  1. Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas

    Clinical and Experimental Metastasis, Vol. 31, Núm. 3, pp. 317-325

2012

  1. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas

    Modern Pathology, Vol. 25, Núm. 8, pp. 1069-1078

2010

  1. Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients

    BMC Cancer, Vol. 10

2009

  1. Significado pronóstico de la angiogénesis en los carcinomas epidermoides de laringe supraglótica tratados con cirugía

    Acta Otorrinolaringologica Espanola, Vol. 60, Núm. 4, pp. 272-277

  2. The relation between Hypoxia-Inducible Factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer

    Journal of Surgical Oncology, Vol. 99, Núm. 6, pp. 373-378

2008

  1. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: Prognostic implications

    Oncology Reports, Vol. 20, Núm. 3, pp. 589-595

2007

  1. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph mode metastases: New results for an old question

    Cancer, Vol. 109, Núm. 9, pp. 1791-1798

2005

  1. Modelo murino ortotópico de carcinoma epidermoide de cabeza y cuello

    Acta Otorrinolaringologica Espanola, Vol. 56, Núm. 3, pp. 89-95